Dr. Tony Holohan:

As I have said already, we are looking at antigen testing. It has already been examined in a number of settings. When we find evidence of the value of it then we apply that evidence. As I have set out already, in symptomatic situations and certain high-risk situations, I am not aware of any published data anywhere that is reported on use in the kinds of sectors or settings that the Deputy has described applied to asymptomatic individuals. I am not aware of any. There is no such data published in any independent studies conducted anywhere in the world that I am aware of. Maybe the Deputy is aware of some but we are not.